{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:25:15Z","timestamp":1787837115454,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"\n Context:<\/jats:title>\n Inhaled levosimendan may act as selective pulmonary vasodilator and avoid systemic side effects of intravenous levosimendan, which include decrease in systemic vascular resistance (SVR) and systemic hypotension, but with same beneficial effect on pulmonary artery pressure (PAP) and right ventricular (RV) function.<\/jats:p>\n <\/jats:sec>\n \n Aim:<\/jats:title>\n The aim of this study was to compare the effect of inhaled levosimendan with intravenous levosimendan in patients with pulmonary hypertension undergoing mitral valve replacement.<\/jats:p>\n <\/jats:sec>\n \n Settings and Design:<\/jats:title>\n The present prospective randomized comparative study was conducted in a tertiary care hospital.<\/jats:p>\n <\/jats:sec>\n \n Subjects and Methods:<\/jats:title>\n \n Fifty patients were randomized into two groups (\n n<\/jats:italic>\n = 25). Group A: Levosimendan infusion was started immediately after coming-off of cardiopulmonary bypass and continued for 24 h at 0.1 mcg\/kg\/min. Group B: Total dose of levosimendan which would be given through intravenous route over 24 h was calculated and then divided into four equal parts and administered through inhalational route 6\n th<\/jats:sup>\n hourly over 24 h. Hemodynamic profile (pulse rate, mean arterial pressure, pulmonary artery systolic pressure [PASP], SVR) and RV function were assessed immediately after shifting, at 1, 8, 24, and 36 h after shifting to recovery.\n <\/jats:p>\n <\/jats:sec>\n \n Statistical Analysis Used:<\/jats:title>\n \n Intragroup analysis was done using paired student\n t<\/jats:italic>\n -test, and unpaired student\n t<\/jats:italic>\n -test was used for analysis between two groups.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n PASP and RV-fractional area change (RV-FAC) were comparable in the two groups at different time intervals. There was a significant reduction in PASP and significant improvement in RV-FAC with both intravenous and inhalational levosimendan. SVR was significantly decreased with intravenous levosimendan, but no significant decrease in SVR was observed with inhalational levosimendan.<\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n Inhaled levosimendan is a selective pulmonary vasodilator. It causes decrease in PAP and improvement in RV function, without having a significant effect on SVR.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aca.aca_19_18","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T08:39:12Z","timestamp":1532507952000},"page":"328-332","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Inhaled Levosimendan versus Intravenous Levosimendan in Patients with Pulmonary Hypertension Undergoing Mitral Valve Replacement"],"prefix":"10.4103","volume":"21","author":[{"given":"Tanveer Singh","family":"Kundra","sequence":"first","affiliation":[{"name":"Department of Cardiac Anaesthesia, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P S","family":"Nagaraja","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anaesthesia, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K S","family":"Bharathi","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anaesthesia, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parminder","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Critical Care, Sir Ganga Ram Hospital, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Manjunatha","sequence":"additional","affiliation":[{"name":"Department of Cardiac Anaesthesia, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250602","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00019501-200502000-00003","article-title":"The right ventricle in pulmonary hypertension","volume":"16","author":"Chin","year":"2005","journal-title":"Coron Artery Dis"},{"key":"R2-20250602","doi-asserted-by":"crossref","first-page":"568095","DOI":"10.4061\/2011\/568095","article-title":"Right ventricular dysfunction and failure in chronic pressure overload","volume":"2011","author":"Simon","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"R3-20250602","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","article-title":"Right ventricular function and failure: Report of a National Heart, Lung, and Blood Institute Working Group on cellular and molecular mechanisms of right heart failure","volume":"114","author":"Voelkel","year":"2006","journal-title":"Circulation"},{"key":"R4-20250602","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/1053-0770(92)90008-U","article-title":"Prognostic value of biventricular function in hypotensive patients after cardiac surgery as assessed by transesophageal echocardiography","volume":"6","author":"Reichert","year":"1992","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R5-20250602","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/0003-4975(95)00526-Q","article-title":"Right ventricular dysfunction in low output syndrome after cardiac operations: Assessment by transesophageal echocardiography","volume":"60","author":"D\u00e1vila-Rom\u00e1n","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R6-20250602","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1053\/j.jvca.2013.01.023","article-title":"Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: The TACTICS trial","volume":"27","author":"Denault","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R7-20250602","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0003-4975(95)00408-D","article-title":"Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations","volume":"60","author":"Goldman","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R8-20250602","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00000542-199002000-00005","article-title":"Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: Effects on pulmonary capillary pressure and ventilation-perfusion distributions","volume":"72","author":"Radermacher","year":"1990","journal-title":"Anesthesiology"},{"key":"R9-20250602","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1053\/j.jvca.2016.01.015","article-title":"Comparative effect of levosimendan and milrinone in cardiac surgery patients with pulmonary hypertension and left ventricular dysfunction","volume":"30","author":"Mishra","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R10-20250602","first-page":"211","article-title":"Levosimendan use in several scenarios of acute heart failure","volume":"90","author":"Tavares","year":"2008","journal-title":"Arq Bras Cardiol"},{"key":"R11-20250602","first-page":"94","article-title":"Effects of levosimendan on systolic function, ergospirometry and cardiac arrhythmia in patients with decompensated advanced heart failure. A six-month follow-up study","volume":"S1","author":"Mavrogeni","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"R12-20250602","first-page":"338","article-title":"Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery","volume":"59","author":"Alvarez","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"R13-20250602","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13054-017-1849-0","article-title":"Levosimendan for patients with severely reduced left ventricular systolic function and\/or low cardiac output syndrome undergoing cardiac surgery: A systematic review and meta-analysis","volume":"21","author":"Sanfilippo","year":"2017","journal-title":"Crit Care"},{"key":"R14-20250602","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00380-008-1077-2","article-title":"Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure","volume":"24","author":"Yilmaz","year":"2009","journal-title":"Heart Vessels"},{"key":"R15-20250602","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1097\/CCM.0b013e3181b0314a","article-title":"Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan","volume":"37","author":"Russ","year":"2009","journal-title":"Crit Care Med"},{"key":"R16-20250602","first-page":"83","article-title":"Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension","volume":"84","author":"Martyniuk","year":"2012","journal-title":"Ter Arkh"},{"key":"R17-20250602","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s11748-008-0301-4","article-title":"Levosimendan and severe pulmonary hypertension during open heart surgery","volume":"56","author":"Cicekcioglu","year":"2008","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R18-20250602","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.jvca.2005.01.039","article-title":"Levosimendan in severe right ventricular failure following mitral valve replacement","volume":"20","author":"Morais","year":"2006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R19-20250602","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00003643-200805001-00556","article-title":"Haemodinamic effects of levosimendan in patients with pulmonary hypertension after cardiac surgical procedures under extracorporeal circulation: 12AP4-6","volume":"25","author":"Amor","year":"2008","journal-title":"Eur J Anaesthesiol"},{"key":"R20-20250602","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/CCM.0b013e3181743e63","article-title":"Inhaled levosimendan reduces mortality and release of proinflammatory mediators in a rat model of experimental ventilator-induced lung injury","volume":"36","author":"Boost","year":"2008","journal-title":"Crit Care Med"},{"key":"R21-20250602","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0003-4975(10)63305-X","article-title":"Mitral valve replacement: A nine-year follow-up of risks and survivals","volume":"27","author":"Chaffin","year":"1979","journal-title":"Ann Thorac Surg"},{"key":"R22-20250602","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/hrt.37.1.74","article-title":"Extreme pulmonary hypertension caused by mitral valve disease. Natural history and results of surgery","volume":"37","author":"Ward","year":"1975","journal-title":"Br Heart J"},{"key":"R23-20250602","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1097\/01.CCM.0000230244.17174.4F","article-title":"Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: A pilot study","volume":"34","author":"Morelli","year":"2006","journal-title":"Crit Care Med"},{"key":"R24-20250602","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1053\/j.jvca.2017.02.081","article-title":"Levosimendan after mitral valve replacement supports right ventricular function better in mitral stenosis patients with moderate to severe pulmonary hypertension","volume":"31","author":"Tewari","year":"2017","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00660469-201821030-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:16:39Z","timestamp":1787836599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00660469-201821030-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_19_18","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}